A carregar...

Cellular Immunotherapy for Neuroblastoma: A Review of Current Vaccine and Adoptive T Cell Therapeutics

Immunotherapy is an attractive option for patients with high risk neuroblastoma due to their poor long-term survival rates after conventional treatment. Neuroblastoma cells are derived from the embryonic neural crest and therefore express tumor antigens not widely seen in normal cells, making them p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Louis, C.U., Brenner, M.K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4122212/
https://ncbi.nlm.nih.gov/pubmed/19199969
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!